Contact
Please use this form to send email to PR contact of this press release:
Tyme’s SM-88 Demonstrates Prolonged Overall Survival in Metastatic Cancer Patients Across Multiple Subgroups
TO:
Please use this form to send email to PR contact of this press release:
Tyme’s SM-88 Demonstrates Prolonged Overall Survival in Metastatic Cancer Patients Across Multiple Subgroups
TO: